[Diagnostic and therapeutic management in a series of 1156 patients with the diagnosis of prostate cancer in Castilla y Leon during 2014.]

Autor: Virseda-Rodríguez ÁJ; Complejo Asistencial Universitario de Salamanca y Grupo de Investigaciones Traslacionales en Urología (IBSALGITUR)., Marcos Asensio S; Enfermera coordinadora de Estudios del Servicio de Urología y grupo de investigaciones GITUR-IBSAL., Núñez-Otero JJ; Complejo Asistencial Universitario de Salamanca y Grupo de Investigaciones Traslacionales en Urología (IBSALGITUR)., García F; Complejo Asistencial de León., Sanz A; Complejo Asistencial de León., Gutiérrez E; Complejo Asistencial Burgos., Serrano JM; Complejo Asistencial Burgos., Valverde S; Hospital Nuestra Señora de Sonsoles. Ávila., Polo C; Hospital Nuestra Señora de Sonsoles. Ávila., Amón-Sesmero JH; Hospital Universitario Rio Hortega. Valladolid., Rodríguez V; Hospital Universitario Rio Hortega. Valladolid., Cortiñas R; Hospital Universitario Clínico de Valladolid., Calleja J; Hospital Universitario Clínico de Valladolid., Adriazola M; Hospital General Rio Carrión. Palencia., Gala L; Hospital General Rio Carrión. Palencia., Bermúdez R; Hospital General de Segovia., Moya I; Hospital General de Segovia., Szczesniewski R; Hospital Santos Reyes. Aranda de Duero., López-Aramburu MÁ; Hospital Santiago Apostol. Miranda de Ebro. España., Gómez-Veiga F; Complejo Asistencial Universitario de Salamanca y Grupo de Investigaciones Traslacionales en Urología (IBSALGITUR).
Jazyk: Spanish; Castilian
Zdroj: Archivos espanoles de urologia [Arch Esp Urol] 2019 Jun; Vol. 72 (5), pp. 463-470.
Abstrakt: Objectives: To evaluate the current clinical practice for patients with Prostate Cancer (CP) in the Health Areas of Castilla y León (CyL) in 2014. METHODS: A retrospective multicenter study was designed to provide data on the diagnosis and treatment of PC in CyL: 87.8% of patients were screened. Descriptive statistics on variables related to characteristics of the patient, the tumor and the treatment modality of the first line to which it was submitted are provided. RESULTS: A total of 1156 new cases of PC were analyzed with a mean age of 68.2 years and a mean PSA of 8.40 ng/ml. The Gleason score (GS) showed 538 (46.2%), 418 (35.9 %) and 200 (17.1%) patients for GS ≤ 6, 7 and  ≥ 8 respectively. 91% of patients (1053 patients) are diagnosed at a localized stage. 56 (4.8%) patients received treatment with active surveillance/ watchful waiting, 423 (36.6%) radical prostatectomy (PR), 348 (30.1%) radiotherapy (RT), 98 (8.4%) brachytherapy (BT) and 170 (14.7%) hormone therapy (HT) respectively.
Conclusions: Differed strategies still accounted for a small percentage of treatments. PR and RT/BT were of choice in patients with localized stages of the disease and younger than 70 years. More advanced stages and older patients were treated with HT mainly. Age is postulated as the main factor involved in therapeutic decision making.
Databáze: MEDLINE
Externí odkaz: